Xglar Refil Injection (3ml Each)

It is administered subcutaneously once daily at any time of day, preferably at the same time each day, to maintain consistent plasma insulin levels. Xglar Refil Injection is suitable for use in both type 1 and type 2 diabetes mellitus as part of a comprehensive diabetes management plan including diet, exercise, and other antidiabetic agents. Dose adjustment should be individualized based on patient’s glycemic response, blood glucose monitoring, and clinical condition.

Patients should be educated on proper injection technique, storage conditions, and recognition and management of hypoglycemia. Caution is advised in patients with renal or hepatic impairment. This product is supplied as a 3ml cartridge for use with compatible insulin delivery devices. Xglar Refil Injection should not be mixed with other insulins or diluted, as this may alter its pharmacokinetic profile and efficacy.